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Abstract
Background: Antimicrobial Stewardship Programs (ASPs) have been promoted to optimize antimicrobial usage and
patient outcomes, and to reduce the emergence of antimicrobial-resistant organisms. However, the best strategies
for an ASP are not definitively established and are likely to vary based on local culture, policy, and routine clinical
practice, and probably limited resources in middle-income countries. The aim of this study is to evaluate structures
and resources of antimicrobial stewardship teams (ASTs) in surgical departments from different regions of the world.
Methods: A cross-sectional web-based survey was conducted in 2016 on 173 physicians who participated in the
AGORA (Antimicrobials: A Global Alliance for Optimizing their Rational Use in Intra-Abdominal Infections) project and
on 658 international experts in the fields of ASPs, infection control, and infections in surgery.
Results: The response rate was 19.4%. One hundred fifty-six (98.7%) participants stated their hospital had a multidisciplinary
AST. The median number of physicians working inside the team was five [interquartile range 4–6]. An infectious disease
specialist, a microbiologist and an infection control specialist were, respectively, present in 80.1, 76.3, and 67.9% of the ASTs.
A surgeon was a component in 59.0% of cases and was significantly more likely to be present in university
hospitals (89.5%, p < 0.05) compared to community teaching (83.3%) and community hospitals (66.7%). Protocols
for pre-operative prophylaxis and for antimicrobial treatment of surgical infections were respectively implemented in
96.2 and 82.3% of the hospitals. The majority of the surgical departments implemented both persuasive and restrictive
interventions (72.8%). The most common types of interventions in surgical departments were dissemination of
educational materials (62.5%), expert approval (61.0%), audit and feedback (55.1%), educational outreach (53.7%), and
compulsory order forms (51.5%).
Conclusion: The survey showed a heterogeneous organization of ASPs worldwide, demonstrating the necessity of a
multidisciplinary and collaborative approach in the battle against antimicrobial resistance in surgical infections, and the
importance of educational efforts towards this goal.
Keywords: Antibiotics, Infections, Surgery, Antimicrobial stewardship
Background
Antimicrobial Stewardship Programs (ASPs) have been
promoted to optimize antimicrobial usage and patient out-
comes and reduce the emergence of antimicrobial-resistant
organisms. However, the best strategies for an ASP are not
definitively established and are likely to vary based on local
culture, policy and routine clinical practice, and probably
limited resources in middle-income countries [1, 2]. Many
hospitals remain without formal programs and those that
do continue to struggle with gaining acceptance across ser-
vice lines [3]. Moreover, identifying optimal efforts to im-
pact system change has been challenging [4].
Restriction strategies may be effective at controlling
use but raise issues of prescriber autonomy and require
a large personnel commitment. Encouraging multidiscip-
linary collaboration within health systems to ensure that
prophylactic, empirical, and targeted use of antimicrobial
agents results in optimal patient outcomes is mandatory
in the current era of antimicrobial resistance.
A panel of experts from the Surgical Infection Society
(SIS) and World Society of Emergency Surgery (WSES)
has recently published a review with the aim of defining
the role of surgeons within the ASPs. The panel proposed
that the best means of improving antimicrobial steward-
ship in surgical units worldwide should involve collab-
oration among various specialties within institutions
including prescribing clinicians and pharmacists [5].
In 2016, a multidisciplinary task force from 79 different
countries joined a global project to develop a consensus
on the rational use of antimicrobials for patients with
intra-abdominal infections (IAIs). The project has been
termed AGORA (Antimicrobials: A Global Alliance
for Optimizing their Rational Use in Intra-Abdominal
Infections) [1].
Recently the Global Alliance for Infections in Surgery
was founded and experts from 87 countries worldwide
joined the highly diverse and skilled International Advis-
ory Board. This alliance, promoted by the WSES, includes
an interdisciplinary group of hospital administrators, epi-
demiologists, infection control specialists, infectious dis-
ease specialists, microbiologists, clinical pharmacologists
and hospital pharmacists, surgeons, and intensivists. The
mission of this alliance is to educate healthcare providers
promoting the standards of care in managing infections in
surgery worldwide [6]. Therefore, this study was con-
ducted to evaluate the structure and resources of anti-
microbial stewardship teams (ASTs) in surgical
departments from different regions of the world.
Methods
We conducted a cross-sectional electronic survey evalu-
ating the structure and resources of ASTs in surgical
departments. The survey was designed by a multidiscip-
linary team of investigators including an epidemiologist,
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a surgeon, an infectious diseases physician, a pharma-
cologist, and a microbiologist. The questionnaire was
piloted among five physicians for face and content
validity.
The 24-item self-administered questionnaire collected
information from multidisciplinary experts—mostly
physicians—about characteristics and composition of
the hospital team, implementation of local procedures,
availability of antimicrobial use monitoring and surveil-
lance systems, presence of an ASP, and related interven-
tions (Additional file 1). An electronic invitation with a
link to the survey was sent to 831 physicians: 173 physi-
cians who participated in the AGORA project [1], and a
large number (658) of international experts in the fields of
antimicrobial stewardship, infection control, and infec-
tions in surgery identified after a thorough investigation
using the PubMed database. The survey was Internet-
based (using http://www.docs.google.com). Participation
was voluntary but not anonymous; however, the confiden-
tiality of respondents and their choices was ensured. No
incentives were provided to the respondents. The study
was open for 6 weeks between September 30 and Novem-
ber 11, 2016. Reminders were sent to all those who had
not replied after 1 and 3 weeks. Due to the characteristics
of the survey, a response rate ranging between 15 and 25%
was expected.
Data were entered in an Excel database (Microsoft
Corporation, Redmond, Washington, USA) and analyzed
using Stata 11.0 software package (StataCorp, College
Station, TX). Descriptive analyses included medians and
interquartile ranges (IQR) for continuous variables or
frequency (%) for categorical variables The two-sided
chi-square or Fisher’s exact test was used for categorical
variables, as appropriate. All tests were two-sided, and
p values of 0.05 or lower were considered statistically
significant.
Results
Baseline data: coverage, response rate, working setting,
and professional profile
A total of 161 (19.4%) of the 831 experts who were
contacted by email completed the survey after two re-
minders. One incomplete survey was excluded from
the study. In two cases the participants were from the
same institution and only one survey was considered.
One hundred fifty-eight responses were included in our
analysis. Participants work settings and professional pro-
files are summarized in Table 1.
The response rate was similar to that of previous stud-
ies promoted by WSES [1, 7, 8].
As in the other WSES studies [1, 7, 8], participants
were not homogeneously distributed across all geographic
regions of the world due to the difficulty in recruiting
participants in some areas of the world. However all
geographic regions were represented in the survey.
Characteristics of the team
One hundred fifty-six (98.7%) participants stated their
hospital had a multidisciplinary AST. Ninety participants
(90/156, 57.7%) declared they were currently members
of the team, with no difference in frequency between dif-
ferent WHO regions. The median number of physicians
working inside the team was five [IQR 4–6]. Characteris-
tics of the team are in Table 2.
One hundred thirty-five (135/158, 85.4%) participants
had at least one surgeon with an interest or skills in
surgical infections within the surgical department of
their hospital; a surgeon was significantly more likely to
be present in university hospitals (89.5%, two-sided chi-
square test p < 0.05) compared to community teaching
hospitals (83.3%) and community hospitals (66.7%).
Implementation of protocols and monitoring systems
Implementation of protocols and monitoring systems in
158 hospitals are reported in Table 3.
The vast majority of respondents (152/158, 96.2%) stated
that their hospitals have a protocol for pre-operative
prophylaxis. The protocol covered all surgical wards in
124 (78.5%) cases. A protocol for antimicrobial treat-
ment of surgical infections was available in 130 (82.3%)
hospitals; however, only 70 (44.3%) had it available in
every surgical ward. One hundred twenty-eight (81.0%)
hospitals had both a protocol for peri-operative prophy-
laxis and for antimicrobial treatment of surgical infections
available, while four (4/158, 2.5%) hospitals lacked both.
Among 130 surgical wards implementing a protocol
for antimicrobial treatment of surgical infections, 97 (74.6%)
participants stated it included interventions to reduce the
duration of therapy, 88 (67.7%) interventions to switch
selected antimicrobials from intravenous-to-oral therapy,
78 (60.0%) interventions for alternative dosing strategies
based on pharmacokinetics and pharmacodynamics,
with significant difference between community hospitals
(11.1%, two-sided Fischer’s exact test p < 0.05) compared
to university (57.0%) and community teaching (60.0%)
hospitals. Thirty-five (26.9%) participants reported the use
of biological markers - such as procalcitonin to decrease
antimicrobial use in critically ill patients.
Implementations of ASPs and related interventions
One hundred fifty-five (155/158, 98.1%) participants
declared their hospital had an ASP running.
Our survey showed that 30 (19.4%) hospitals have
developed persuasive interventions, 17 (11.0%) restrict-
ive interventions and 108 (69.7%) both of them.
Sartelli et al. World Journal of Emergency Surgery  (2017) 12:34 Page 3 of 11
Twenty-three surgical departments (23/136, 16.9%)
have developed persuasive interventions, 14 (10.3%) re-
strictive interventions and 99 (72.8%) both of them.
The most common types of interventions in surgical
departments were dissemination of educational materials
(62.5%), expert approval (61.0%), audit and feedback
(55.1%), educational outreach (53.7%), and compulsory
order forms (51.5%).
Types of ASPs and related interventions in surgical
departments and in all hospital wards are described in
detail in Table 4.
Six (6/41, 14.6%) surgical departments implementing a
formulary restriction do not perform any monitoring
system of used antimicrobials, and 4 (4/41, 9.8%) do not
carry out any systematic reports about resistance data.
Furthermore, 6 (7/70, 10.0%) surgical departments using
a compulsory order form do not perform any monitoring
system of used antimicrobials, and 11 (11/70, 15.7%) do
not carry out any systematic reports about resistance data.
One hundred twenty-five (125/158, 79.1%) participants
stated their hospital had carried out structural interventions
to improve ASPs in the last 5 years. Sixty-nine (43.7%)
changed from paper to computerized records, 74 (46.8%)
implemented rapid laboratory testing, 32 (20.3%) intro-
duced computerized decision support systems, 69 (43.7%)
introduced organization of quality monitoring mechanisms
and 29 (18.4%) implemented other structural interventions.
Characteristics of the implementation of protocols,
monitoring systems, and ASPs interventions in surgical
departments are detailed in Table 5.
Discussion
Antimicrobial stewardship programs (ASP) are a key strat-
egy to curb the spread of antibiotic resistance [3, 9]. The
best strategies for an ASP are not definitively established
and are likely to vary based on local routine clinical prac-
tice [7], despite several guidelines on the topic [9, 10].
Table 1 Participants’ working settings and professional profiles
Characteristics African region
n = 8
Eastern- Mediterranean
region n = 13
European
region
n = 67
Region of
Americas
n = 47
South-East
Asia region
n = 8
Western Pacific
region n = 15
Total
n = 158
Type of hospital, n (%)
- University hospital 5 (62.5) 6 (46.1) 50 (74.6) 35 (74.5) 6 (75.0) 12 (80.0) 114 (72.1)
- Community teaching hospital 2 (25.0) 3 (23.1) 14 (20.9) 9 (19.1) 1 (12.5) 1 (6.7) 30 (19.0)
- Community hospital 0 2 (15.4) 3 (4.5) 1 (2.1) 1 (12.5) 2 (13.3) 9 (5.7)
- Other 1 (12.5) 2 (15.4) 0 2 (4.3) 0 0 5 (3.2)
Hospital setting, n (%)
- Urban 5 (62.5) 10 (76.9) 65 (97.0) 44 (93.6) 6 (75.0) 14 (93.3) 144 (91.1)
- Suburban 3 (37.5) 3 (23.1) 2 (3.0) 1 (2.1) 2 (25.0) 0 11 (7.0)
- Rural 0 0 0 2 (4.3) 0 1 (6.7) 3 (1.9)
Hospital inpatient beds, n (%)
- ≤100 0 2 (15.4) 3 (4.5) 1 (2.1) 0 0 6 (3.8)
- 101–500 3 (37.5) 5 (38.5) 15 (22.4) 10 (21.3) 2 (25.0) 3 (20.0) 38 (24.1)
- 501–1000 3 (37.5) 5 (38.5) 27 (40.3) 28 (59.6) 3 (37.5) 1 (6.7) 67 (42.4)
- ≥ 1000 2 (25.0) 1 (7.7) 22 (32.8) 8 (17.0) 3 (37.5) 11 (73.3) 47 (29.7)
Profession, n (%)
Epidemiologist 1 (12.5) 0 2 (3.0) 1 (2.1) 0 0 4 (2.5)
Hospital administrator 0 0 0 0 0 0 0
Clinical pharmacologist 0 1 (7.7) 0 4 (8.5) 1(12.5) 1 (6.7) 7 (4.4)
Hospital pharmacist 0 0 1 (1.5) 1 (2.1) 1 (12.5) 1 (6.7) 4 (2.5)
Infection control specialist 0 0 1 (1.5) 1 (2.1) 0 0 2 (1.3)
Infectious diseases specialist 0 4 (30.8) 10 (14.9) 10 (21.3) 0 5 (33.3) 29 (18.4)
Intensivist 1 (12.5) 0 5 (7.5) 2 (4.3) 0 1 (6.7) 9 (5.7)
Microbiologist 3 (37.5) 3 (23.1) 1 (1.5) 1 (2.1) 3 (37.5) 0 11 (7.0)
Surgeon 3 (37.5) 5 (38.5) 44 (65.7) 24 (51.1) 3 (37.5) 6 (40.0) 85 (53.8)
Other 0 0 3 (4.5) 3 (6.4) 0 1 (6.7) 7 (4.4)
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Successful ASPs should focus on collaboration between
healthcare professionals in order to share knowledge and
best practices. It is essential for an ASP to have at least
one member who is an infectious diseases specialist.
Pharmacists with advanced training or longstanding
clinical experience in infectious diseases are also key ac-
tors for the design and implementation of the stewardship
program interventions [11]. Infection control specialists
and hospital epidemiologists should coordinate efforts
on monitoring and preventing healthcare-associated in-
fections and in analyzing and reporting “real-time” data
to prevent infections, improve antimicrobial use, and
minimize secondary spread of resistance. Microbiologists
should actively guide the proper use of tests and the flow
of laboratory results. Being involved in providing surveil-
lance data on antimicrobial resistance, they should provide
periodic reports on antimicrobial resistance data allowing
the multidisciplinary team to determine the ongoing
burden of antimicrobial resistance in the hospital. More-
over, timely and accurate reporting of microbiology sus-
ceptibility test results allows selection of more appropriate
targeted therapy, and may help reduce broad-spectrum
antimicrobial use.
Surgeons with adequate knowledge in surgical infec-
tions and surgical anatomy when involved in ASPs may
audit antibiotic prescriptions, provide feedback to the
prescribers and integrate best practices of antimicrobial
use among surgeons, and act as champions among col-
leagues. Although many surgeons are aware of the prob-
lem of antimicrobial resistance, most underestimate it in
their own hospital [1]. Very few studies have been pub-
lished on the role of ASPs in general surgical departments.
In 2015, Cakmakci [12] suggested that the engagement of
surgeons in ASPs might be crucial to their success. In
2013, however, Duane et al. showed poor compliance of
surgical services with ASP recommendations [13]. Sur-
geons need to take part in addressing the global issue
of antimicrobial resistance. Failure to do so will be cata-
strophic to patients and programs [3].
Infections are the main factors contributing to mortal-
ity in intensive care units (ICU) [14].
Intensivists have a critical role in treating multidrug
resistant organisms in ICUs in critically ill patients. They
have a crucial role in prescribing antimicrobial agents
for our most challenging patients and are at the forefront
of a successful ASP [15].
Finally, without adequate support from hospital admin-
istration, the ASP will be inadequate or inconsistent since
the programs do not generate revenue [16]. Engagement
of hospital administration has been confirmed as a key
factor for both developing and sustaining an ASP [17].
In most cases, our survey demonstrated that ASPs do
not involve a true multi-disciplinary approach.
An infectious diseases specialist and a hospital pharma-
cist were part of the team in 125 (80.1%) and in 95 (60.9%)
cases, respectively. Only 87 (55.8%) teams included both
an infectious diseases specialist and a hospital pharmacist.
An infection control specialist and a hospital epidemiolo-
gist were part of the team in 106 (67.9%) and in 64 (41.0%)
cases, respectively. It is possible that in some hospitals,
Table 2 Characteristics of the team in 156 hospitals
Characteristics n (%)
Components
- Epidemiologist 64 (41.0)
- Hospital administrator 73 (46.8)
- Clinical pharmacologist 8 (5.1)
- Hospital pharmacist 95 (60.9)
- Infection control specialist 106 (67.9)
- Infectious disease specialist 125 (80.1)
- Intensivist 76 (48.7)
- Microbiologist 119 (76.3)
- Surgeon 92 (59.0)
- Other 11 (7.1)
- Infectious disease specialist AND hospital
pharmacologist/pharmacist
87 (55.8)
Frequency of meetings
- More than once a week 15 (9.6)
- Once a week 26 (16.7)
- Twice a month 13 (8.3)
- Once a month 58 (37.2)
- Less than once a month 27 (17.3)
- Only as necessary 17 (10.9)
Table 3 Implementation of protocols and monitoring systems in 158 hospitals
Implementation of
protocols and
monitoring systems
All hospital wards
n (%)
Some hospital wards, including
surgical wards
n (%)
Some hospital wards, not
including surgical wards
n (%)
No hospital wards
n (%)
Every surgical wards Some surgical wards
- SAP protocol NA 124 (78.5) 28 (17.7) NA 6 (3.8)
- TIS protocol NA 70 (44.3) 60 (38.0) NA 28 (17.7)
- UAMS 84 (53.2) 45 (28.5) 9 (5.7) 20 (12.7)
- RDSR 104 (65.8) 26 (16.5) 7 (4.4) 21 (13.3)
SAP Surgical antimicrobial prophylaxis, TIS therapy for infections in surgery, UAMS used antimicrobial monitoring system, RDSR resistance data systematic report
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AMS and infection prevention and control team are two
separate entities, which collaborate. A microbiologist was
part of the team in 119 (76.3%) cases. A surgeon was part
of the team in 92 (59.0%) cases and an intensivist in 76
(48.6%) cases. A hospital administrator was part of the
team only in 73 (46.8%) cases. Interestingly a surgeon
was significantly more likely to be part of the team in
university hospitals (89.5%, two-sided chi-square test
p < 0.05) compared to community teaching (83.3%) and
community non-teaching hospital (66.7%).
Strategies of ASPs should be tailored based on individ-
ual hospital characteristics and personnel and resources
available. The Infectious Diseases Society of America/
Society for Healthcare Epidemiology of America (IDSA/
SHEA) guidelines identified two core proactive evidence-
based strategies and several supplemental strategies for
promoting antimicrobial stewardship [7, 8]: first, a re-
strictive strategy based on a proactive strategy of either
formulary restriction or a requirement for pre-approval
for specific drugs or both, and second, a persuasive strat-
egy of performing prospective audit with intervention and
feedback to the prescriber.
Our survey showed that 23 (16.9%) surgical departments
have developed persuasive interventions, 14 (10.3%) re-
strictive interventions and 99 (72.8%) both of them. ASP
policies should be based on both international/national
antibiotic guidelines, and tailored to local microbiology
and resistance patterns. Local clinical practice guidelines
and algorithms can be an effective way to standardize
prescribing practices based on the country’s epidemiology.
Standardizing a shared protocol of antimicrobial prophy-
laxis should represent the first step of any Antimicrobial
Stewardship program.
One hundred fifty-two (96.2%) participants stated their
hospitals have a protocol for surgical antibiotic prophy-
laxis. Among the 158 hospitals, a protocol for antibiotic
prophylaxis is present in all surgical wards in 124
(78.5%) of hospitals while only in some surgical wards in
28 (17.7%) hospitals.
A protocol for antibiotic treatment was present in all
surgical wards in 70 (44.3%) hospitals, while only in some
surgical wards in 60 (38.0%) hospitals. Among 130 hospi-
tals implementing a protocol for antimicrobial treatment
of surgical infections, 97 (74.6%) participants stated that it
included interventions to reduce the duration of therapy,
88 (67.7%) interventions to switch select antimicrobials
from intravenous-to-oral therapy, 78 (60.0%) interventions
for alternative dosing strategies based on pharmacokinetic
and pharmacodynamic principles, with substantial dif-
ference between community hospitals (11.1%, two-sided
Fischer’s exact test p < 0.05), university (57.0%) and
community teaching (60.0%) ones. Thirty-five (26.9%)
participants admitted to the use of biological markers -
such as procalcitonin - to decrease antimicrobial use in
critically ill patients.
In any healthcare setting, a significant amount of time
and energy should be spent on infection control. Surveil-
lance studies can help clinicians to identify trends in
Table 4 Difference in type of ASPs and related implemented types of interventions in surgical departments and non-surgical
departments
Characteristics Surgical departments, n = 136
n (%)
Other departments, n = 19
n (%)
P value Total, n = 155
n (%)
Type of ASPs
- Persuasive interventions 23 (16.9) 7 (36.8) 0.06a 30 (19.4)
- Restrictive interventions 14 (10.3) 3 (15.8) 0.44a 17 (11.0)
- Both 99 (72.8) 9 (47.4) <0.05 108 (69.7)
Type of interventions
- Dissemination of educational materials 85 (62.5) 8 (42.1) 0.15 93 (60.0)
- Reminders 56 (41.2) 8 (42.1) 1.00 64 (41.3)
- Audit and feedback 75 (55.1) 4 (21.1) <0.05 79 (51.0)
- Educational outreach 73 (53.7) 10 (52.6) 1.00 83 (53.6)
- Other persuasive interventions 23 (16.9) 3 (15.8) 1.00a 26 (16.8)
- Compulsory order form 70 (51.5) 7 (36.8) 0.34 77 (49.7)
- Expert approval 83 (61.0) 5 (26.3) <0.05 88 (56.8)
- Restriction by removal 41 (30.1) 2 (10.5) 0.13 43 (27.7)
- Review and make changes 36 (26.5) 1 (5.3) <0.05a 37 (23.9)
- Other restrictive interventions 10 (7.4) 3 (15.8) 0.20a 13 (8.4)
All p values were calculated using two-sided chi-square test unless otherwise noted
ASP antimicrobial stewardship program
aCalculated using two-sided Fisher’s exact test
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pathogens incidence and antimicrobial resistance, includ-
ing identification of emerging pathogens at local level.
The survey showed that 130 (83.3%) surgical departments
had systematic reports about resistance data.
Hospital pharmacists inside the multidisciplinary team
should negotiate with hospital administration to obtain
adequate and necessary infrastructure to measure anti-
microbial use. Regular feedback about antimicrobial
consumption can be an important determinant for change
for healthcare professionals and policy makers to expedite
progress towards prudent use of antimicrobials. The sur-
vey showed that 129 (81.6%) surgical departments had an
antimicrobial monitoring system.
Interestingly, 6 (6/41, 14.6%) surgical departments
implementing a formulary restriction do not perform
any monitoring system of used antimicrobials, and 4
(4/41, 9.8%) do not carry out any systematic reports
about resistance data. Furthermore, 6 (7/70, 10.0%) surgi-
cal departments using a compulsory order form do not
perform any monitoring system of used antimicrobials,
and 11 (11/70, 15.7%) do not carry out any systematic
reports about resistance data. In institutions that use
restrictive interventions, monitoring overall trends in
antimicrobial use and systematic reports about resist-
ance data should be necessary to assess and respond to
such shifts in use.
The ultimate goal of any stewardship program should
be to stimulate a behavioral change in prescribing prac-
tices. In this context, education of prescribers is crucial
to convince clinicians to use antibiotics judiciously.
However, without concurrent interventions education alone
is of little value. In this regard, various stewardship inter-
ventions have been implemented with the aim of improving
adherence to guidelines. Where these interventions have
been clinician focused, accumulating evidence suggests that
educational interventions are mostly ineffective and result
in insignificant changes to overall compliance [17]. It is
possible that this might relate to cognitive dissonance, a
process in which clinician-focused education fails to engage
prescribers effectively, allowing them to ignore the evidence
and to continue with their regular habits and practices. Al-
ternative strategies of improving antibiotic management of
surgical patients are needed and these may include
guidance of clinicians in the institutional process of im-
provement, which has not as yet been addressed in guide-
lines [17]. The answer may lie within the principles and
imperatives contained with the change of processes in
hospitals.
It is highly important that faculty in academic medical
centers and teaching hospitals focus on fundamental
antibiotic stewardship principles in their preclinical and
clinical curricula [18].
The survey found that dissemination of educational
materials and educational outreach were developed
respectively in 85 cases (62.5%) and 73 (53.7%) surgical
departments.
This study has several limitations: with a response rate
of just 19.4% we have to consider a response bias, and it
is possible that non-participating physicians may have
been less interested in ASPs than the participants and
therefore it is possible that results are biased towards a
better picture than it actually is. Furthermore, the study
was conducted in a sample of physicians who partici-
pated in the AGORA project, and selecting international
experts in the field again potentially resulting in an over-
representation of hospitals with a considerably active
ASP. No stratification or sampling according to medical
specialty were pre-planned to ensure that all stakeholders
were adequately represented, and finally our questionnaire
was self-reported, has not been externally validated, and
was evaluated in a single institution. The major strength
of the study is its multinational (global) and multidis-
ciplinary approach, to our best knowledge the first in
this setting. Thus, our survey provides a benchmark to
all interested stakeholders; it can be repeated over time
to explore if better uniformity on a global platform of
healthcare environments would develop in the future,
and may be used to build consensus around the best
practices in the field of prevention of surgical infections
and rational use of antibiotics in a future project.
Conclusions
The results of the survey showed a heterogeneous
organization of ASPs worldwide and demonstrated the
need for a cohesive approach in order limit the emer-
gence of antimicrobial resistance in surgical infections.
Successful ASPs should focus on collaboration between
all healthcare professionals in order to gain the wider-
possible acceptance, share knowledge and spread best
clinical practices. The main bias of the survey is the
low response rate.
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